You are here

Article Text

Article menu
Download PDFPDF
Controversy
Expectations regarding cognitive enhancement create substantial challenges
  1. E Racine1,
  2. C Forlini2
  1. 1
    Neuroethics Research Unit, Institut de recherches cliniques de Montréal, Department of Medicine and Department of Social and Preventive Medicine, Université de Montréal, and Department of Neurology and Neurosurgery & Biomedical Ethics Unit, McGill University, Montréal, Canada
  2. 2
    Neuroethics Research Unit, Institut de recherches cliniques de Montréal, Montréal, Canada
  1. Eric Racine, Neuroethics Research Unit, IRCM, 110 avenue des Pins Ouest, Montréal QC H2W lR7, Canada; eric.racine{at}ircm.qc.ca

Abstract

A recent discussion on cognitive enhancers has caused some controversy in the ethics and neuroscience fields by coming out in favour of making neuropharmaceuticals with enhancing properties available for general consumption. We highlight in this brief commentary why concerns regarding efficacy and safety, demands on resources, and public health are substantive enough to warrant serious reconsideration before pharmaceutical performance enhancement can be widely supported.

https://doi.org/10.1136/jme.2009.030460

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Funding: Support for this publication comes from the Social Sciences and Humanities Research Council of Canada, the Canadian Institutes of Health Research and the Fonds de la recherche en santé du Québec.

    • Competing interests: None declared.

    • Provenance and peer review: Not commissioned; externally peer reviewed.

    Linked Articles

    • The concise argument
      The concise argument
      Søren Holm
      Journal of Medical Ethics 2009; 35 461-461 Published Online First: 30 Jul 2009. doi: 10.1136/jme.2009.031898

    Other content recommended for you